(R)-4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氢-[1,1'-联苯]-2-基)甲基)哌嗪-1-基)-N-((4-((4-吗啉-1-(苯硫基)丁烷-2-基)氨基)-3-((三氟甲基)磺酰)苯基)磺酰)苯甲酰胺
Navitoclax (Synonyms: ABT-263; A-855071)
ChemLeader
产品编号:
CAS No.:
MDLNo:
分子式:
分子量:
选择规格
5 mg 10 mg
产品库存
In-stock
目录价格
¥480.00
会员价格
产品库存
In-stock
目录价格
¥760.00
会员价格
选择数量
- +
基本信息
中文名称(R)-4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氢-[1,1'-联苯]-2-基)甲基)哌嗪-1-基)-N-((4-((4-吗啉-1-(苯硫基)丁烷-2-基)氨基)-3-((三氟甲基)磺酰)苯基)磺酰)苯甲酰胺
英文名称 Navitoclax (Synonyms: ABT-263; A-855071)
CAS号923564-51-6
分子式C47H55ClF3N5O6S3
分子量974.61
外观White to light yellow powder
储存条件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
安全信息
产品详情

Navitoclax, also known as ABT-263, is an orally bioavailable, synthetic small-molecule antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w and prevents their binding to the apoptotic effectors Bax and Bak proteins, which may trigger apoptosis in tumor cells overexpressing Bcl-2, Bcl-XL, and Bcl-w.
Tags: buy Navitoclax (ABT-263) | purchase Navitoclax (ABT-263) | Navitoclax (ABT-263) cost | order Navitoclax (ABT-263) | Navitoclax (ABT-263) chemical structure | Navitoclax (ABT-263) in vivo | Navitoclax (ABT-263) in vitro | Navitoclax (ABT-263) formula | Navitoclax (ABT-263) molecular weight

相关文献
相关产品
抱歉,暂时没有相关产品
浏览记录
(R)-4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氢-[1,1'-联苯]-2-基)甲基)哌嗪-1-基)-N-((4-((4-吗啉-1-(苯硫基)丁烷-2-基)氨基)-3-((三氟甲基)磺酰)苯基)磺酰)苯甲酰胺